Shriram Bhosle

Oct 18, 2024 | nature.com | Matthew A. Coelho |Magdalena E. Strauss |Shriram Bhosle |Sara Vieira |Daniela Conticelli |Jonas Koeppel | +4 more

AbstractDrug resistance is a principal limitation to the long-term efficacy of cancer therapies. Cancer genome sequencing can retrospectively delineate the genetic basis of drug resistance, but this requires large numbers of post-treatment samples to nominate causal variants.